Target cells for the activity of a synthetic adjuvant: muramyl dipeptide.
D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D000818:Animals; D000917:Antibody Formation; D000941:Antigens; D001402:B-Lymphocytes / Q000276:immunology; D001854:Bone Marrow Cells; D016026:Bone Marrow Transplantation; D004912:Erythrocytes / Q000276:immunology; D005260:Female; D006020:Glycopeptides / Q000494:pharmacology*; D008264:Macrophages / Q000187:drug effects / Q000276:immunology; D051379:Mice; D008808:Mice, Inbred CBA; D009112:Muramic Acids / Q000494:pharmacology; D010587:Phagocytosis / Q000187:drug effects; D011828:Radiation Chimera; D013154:Spleen / Q000276:immunology / Q000637:transplantation; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology*; D014185:Transplantation, Isogeneic
D000276:Adjuvants, Immunologic; D000941:Antigens; D006020:Glycopeptides; D009112:Muramic Acids